Pharma company ranking based on access to medicine in developing countries 2018

This statistic depicts the Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries in 2018. In that year, GlaxoSmithKline with 4.01 had the highest total score. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.

Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries in 2018*

Indicator score from 1 (lowest) to 5 (highest)
GlaxoSmithKline plc4.01
Novartis AG3.21
Johnson & Johnson3.05
Merck KGaA2.9
Takeda Pharmaceutical Co.2.75
Novo Nordisk A/S2.68
Sanofi2.49
Eisai Co. Ltd.2.48
AstraZeneca plc2.48
Roche Holding Ltd.2.38
Pfizer Inc.2.34
Merck & Co Inc.2.32
Gilead Sciences2.29
Boehringer-Ingelheim GmbH2.11
Bristol-Meyers Squibb Co.2.03
Bayer AG1.88
AbbVie Inc.1.88
Daiichi Sankyo Co. Ltd.1.77
Astellas Pharma Inc.1.46
Eli Lilly & Co.1.27
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

November 2018

Region

Worldwide

Survey time period

2018

Supplementary notes

* The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
The Index uses a framework that evaluates company activities in seven areas of activity, or technical areas, considered to be key to enhancing access to medicine in developing countries, and across four important aspects of action, or strategic pillars.
A score of zero means lowest and five signifies highest indicator score among the company set.
Merck & Co., Inc. is known as MSD outside the US and Canada. Merck KGaA’s healthcare division is known as EMD Serono in the US and Canada.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Monsanto-Bayer"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.